Chollet P - Search Results

1

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

Cortes J, O'Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, Chollet P, Manikas A, Diéras V, Delozier T, Vladimirov V, Cardoso F, Koh H, Bougnoux P, Dutcus CE, Seegobin S, Mir D, Meneses N, Wanders J, Twelves C; EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389) investigators. Cortes J, et al. Among authors: chollet p. Lancet. 2011 Mar 12;377(9769):914-23. doi: 10.1016/S0140-6736(11)60070-6. Epub 2011 Mar 2. Lancet. 2011. PMID: 21376385 Clinical Trial.

2

A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.

Delozier T, Guastalla JP, Yovine A, Levy C, Chollet P, Mousseau M, Delva R, Coeffic D, Vannetzel JM, Zazzi ES, Brienza S, Cvitkovic E. Delozier T, et al. Among authors: chollet p. Anticancer Drugs. 2006 Oct;17(9):1067-73. doi: 10.1097/01.cad.0000231475.77159.aa. Anticancer Drugs. 2006. PMID: 17001180 Clinical Trial.

3

Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers.

Abrial C, Mouret-Reynier MA, Amat S, Sillet-Bach I, Bougnoux P, Delva R, Cure H, Dauplat J, Penault-Llorca F, Chollet P. Abrial C, et al. Among authors: chollet p. Med Oncol. 2005;22(3):233-40. doi: 10.1385/MO:22:3:233. Med Oncol. 2005. PMID: 16110134

4

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer.

Abrial SC, Penault-Llorca F, Delva R, Bougnoux P, Leduc B, Mouret-Reynier MA, Mery-Mignard D, Bleuse JP, Dauplat J, Curé H, Chollet P. Abrial SC, et al. Among authors: chollet p. Breast Cancer Res Treat. 2005 Dec;94(3):255-63. doi: 10.1007/s10549-005-9008-8. Breast Cancer Res Treat. 2005. PMID: 16267618

5

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patients.

Dieras V, Bougnoux P, Petit T, Chollet P, Beuzeboc P, Borel C, Husseini F, Goupil A, Kerbrat P, Misset JL, Bensmaïne MA, Tabah-Fisch I, Pouillart P. Dieras V, et al. Among authors: chollet p. Ann Oncol. 2002 Feb;13(2):258-66. doi: 10.1093/annonc/mdf018. Ann Oncol. 2002. PMID: 11886003 Free article. Clinical Trial.

6

Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).

Chollet P, Schöffski P, Weigang-Köhler K, Schellens JH, Cure H, Pavlidis N, Grünwald V, De Boer R, Wanders J, Fumoleau P; EORTC Early Clinical Studies Group. Chollet P, et al. Eur J Cancer. 2003 Jun;39(9):1264-70. doi: 10.1016/s0959-8049(03)00237-5. Eur J Cancer. 2003. PMID: 12763215 Clinical Trial.

7

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.

Amat S, Bougnoux P, Penault-Llorca F, Fétissof F, Curé H, Kwiatkowski F, Achard JL, Body G, Dauplat J, Chollet P. Amat S, et al. Among authors: chollet p. Br J Cancer. 2003 May 6;88(9):1339-45. doi: 10.1038/sj.bjc.6600916. Br J Cancer. 2003. PMID: 12778058 Free PMC article. Clinical Trial.

8

A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993).

Coleman RE, Biganzoli L, Canney P, Dirix L, Mauriac L, Chollet P, Batter V, Ngalula-Kabanga E, Dittrich C, Piccart M. Coleman RE, et al. Among authors: chollet p. Eur J Cancer. 2006 May;42(7):882-7. doi: 10.1016/j.ejca.2005.12.011. Epub 2006 Mar 7. Eur J Cancer. 2006. PMID: 16520033 Clinical Trial.

9

Phase II study of cystemustine in advanced renal cancer.

Chauvergne J, Kerbrat P, Adenis A, Chollet P, Fargeot P, Pujade-Lauraine E, Dieras V, Madelmont JC, Lentz MA, Toulouse C, et al. Chauvergne J, et al. Among authors: chollet p. Eur J Cancer. 1995;31A(1):130-1. doi: 10.1016/0959-8049(94)00375-f. Eur J Cancer. 1995. PMID: 7695969 Clinical Trial. No abstract available.

10

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.

Pouget M, Abrial C, Planchat E, Van Praagh I, Arbre M, Kwiatkowski F, Dubray-Longeras P, Devaud H, Dohou J, Herviou P, Mahammedi H, Durando X, Chollet P, Mouret-Reynier MA. Pouget M, et al. Among authors: chollet p. Oncology. 2015;89(6):319-31. doi: 10.1159/000437230. Epub 2015 Oct 13. Oncology. 2015. PMID: 26457979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page